Paragon [FNA] vs Novocure [NVCR] Detailed Stock Comparison

Paragon 28 Inc.

NYSE
Loading...

Novocure Ltd.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Paragon 28 Inc. wins in 7 metrics, Novocure Ltd. wins in 11 metrics, with 0 ties. Novocure Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Paragon 28 Inc. Novocure Ltd. Better
P/E Ratio (TTM) N/A -10.32 N/A
Price-to-Book Ratio 8.41 4.04 Novocure Ltd.
Debt-to-Equity Ratio 86.22 72.95 Novocure Ltd.
PEG Ratio -27.85 0.16 Novocure Ltd.
EV/EBITDA -52.91 -8.82 Novocure Ltd.
Profit Margin (TTM) -21.33% -20.79% Novocure Ltd.
Operating Margin (TTM) -8.97% -21.33% Paragon 28 Inc.
Return on Equity -36.39% -38.89% Paragon 28 Inc.
Return on Assets (TTM) -8.18% -9.06% Paragon 28 Inc.
Free Cash Flow (TTM) $-44.10M $-75.68M Paragon 28 Inc.
1-Year Return 33.57% -10.83% Paragon 28 Inc.
Price-to-Sales Ratio (TTM) 4.29 2.16 Novocure Ltd.
Enterprise Value $1.18B $1.19B Novocure Ltd.
EV/Revenue Ratio 4.59 1.82 Novocure Ltd.
Gross Profit Margin (TTM) 72.92% 75.82% Novocure Ltd.
Revenue per Share (TTM) $3 $6 Novocure Ltd.
Earnings per Share (Diluted) $-0.66 $-1.22 Paragon 28 Inc.
Beta (Stock Volatility) 1.47 0.82 Novocure Ltd.
Short % of Float 2.13% 12.45% Paragon 28 Inc.

Paragon 28 Inc. vs Novocure Ltd. Stock Performance Analysis

Loading Price Chart...

FNA
NVCR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Paragon 28 Inc.0.00%0.54%0.54%0.54%0.54%0.54%
Novocure Ltd.11.39%-4.94%-4.61%21.43%36.75%23.09%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Paragon 28 Inc.33.57%-29.09%-30.04%-30.04%-30.04%-30.04%
Novocure Ltd.-10.83%-78.57%-91.72%57.34%-6.78%-6.78%

Performance & Financial Health Analysis: Paragon 28 Inc. vs Novocure Ltd.

MetricFNANVCR
Market Information
Market Cap i$1.10B$1.46B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,859,6371,138,762
90 Day Avg. Volume i2,418,2791,141,014
Last Close$13.09$17.99
52 Week Range$4.65 - $13.13$9.82 - $19.25
% from 52W High-0.30%-6.55%
All-Time High$25.41 (Nov 08, 2021)$232.76 (Jun 21, 2021)
% from All-Time High-48.48%-92.27%
Growth Metrics
Quarterly Revenue Growth0.19%0.08%
Quarterly Earnings Growth0.18%0.08%
Financial Health
Profit Margin (TTM) i-0.21%-0.21%
Operating Margin (TTM) i-0.09%-0.21%
Return on Equity (TTM) i-0.36%-0.39%
Debt to Equity (MRQ) i86.2272.95
Cash & Liquidity
Book Value per Share (MRQ)$1.56$3.03
Cash per Share (MRQ)$0.41$3.93
Operating Cash Flow (TTM) i$-27,148,000$-49,031,000
Levered Free Cash Flow (TTM) i$-22,887,124$-37,975,376
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Paragon 28 Inc. vs Novocure Ltd.

MetricFNA (May 17, 2025)NVCR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A-10.32
Forward P/E i-27.85-10.49
PEG Ratio i-27.850.16
Price to Sales (TTM) i4.292.16
Price to Book (MRQ) i8.414.04
Market Capitalization
Market Capitalization i$1.10B$1.46B
Enterprise Value i$1.18B$1.19B
Enterprise Value Metrics
Enterprise to Revenue i4.591.82
Enterprise to EBITDA i-52.91-8.82
Risk & Other Metrics
Beta i1.470.82
Book Value per Share (MRQ) i$1.56$3.03

Financial Statements Comparison: Paragon 28 Inc. vs Novocure Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFNA (2024)NVCR (2025)
Revenue/Sales i256.18M655.35M
Cost of Goods Sold i64.69M166.88M
COGS % of Revenue i25.3%25.5%
Gross Profit i191.49M488.47M
Gross Margin i74.7%74.5%
Research & Development i27.07M224.54M
Operating Income (EBIT) i-40.78M-153.80M
Operating Margin i-15.9%-23.5%
EBITDA i-23.40M-100.24M
EBITDA Margin i-9.1%-15.3%
Pre-Tax Income i-53.48M-136.25M
Pre-Tax Income % of Revenue i-20.9%-20.8%
Income Tax i1.16M-23,000
Income Tax % of Revenue i0.5%0.0%
Net Income (Profit) i-54.64M-136.23M
Profit Margin i-21.3%-20.8%

Balance Sheet & Liquidity Metrics

MetricFNA (2024)NVCR (2025)
Cash & Equivalents i34.58M93.55M
Total Current Assets i168.85M646.73M
Total Current Assets % of Revenue i65.9%98.7%
Total Current Liabilities i48.13M223.23M
Total Current Liabilities % of Revenue i18.8%34.1%
Long-Term Debt i110.05M236.69M
Long-Term Debt % of Revenue i43.0%36.1%
Total Shareholders Equity i130.59M340.47M
Retained Earnings i-178.29M-1.29B
Retained Earnings % of Revenue i-69.6%-196.9%
Property, Plant & Equipment i73.83M115.82M

Cash Flow Statement Comparison

MetricFNA (2024)NVCR (2025)
Operating Cash Flow i-41.59M-50.83M
Operating Cash Flow % of Revenue i-16.2%-7.8%
Capital Expenditures i-14.53M-26.65M
Free Cash Flow i-44.10M-75.68M
FCF Margin i-17.2%-11.5%
Debt Repayment i-640,000-560.95M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFNANVCR
Shares Short i1.07M9.06M
Short Ratio i0.646.78
Short % of Float i2.13%12.45%
Shares Outstanding i83.86M112.49M
Float Shares i44.19M94.63M
% Held by Insiders i31.22%9.32%
% Held by Institutions i50.84%85.24%
% Held by Public i17.94%5.44%

Dividend Analysis & Yield Comparison: Paragon 28 Inc. vs Novocure Ltd.

MetricFNANVCR
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A